JIBCX
Price
$68.39
Change
-$0.07 (-0.10%)
Updated
Aug 15 closing price
Net Assets
5.91B
VIGRX
Price
$237.87
Change
-$0.79 (-0.33%)
Updated
Aug 15 closing price
Net Assets
324.3B
Interact to see
Advertisement

JIBCX vs VIGRX

Header iconJIBCX vs VIGRX Comparison
Open Charts JIBCX vs VIGRXBanner chart's image
JHancock Blue Chip Growth 1
Price$68.39
Change-$0.07 (-0.10%)
VolumeN/A
Net Assets5.91B
Vanguard Growth Index Investor
Price$237.87
Change-$0.79 (-0.33%)
VolumeN/A
Net Assets324.3B
JIBCX vs VIGRX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
JIBCX vs. VIGRX commentary
Aug 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JIBCX is a Buy and VIGRX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIGRX has more cash in the bank: 324B vs. JIBCX (5.91B). VIGRX pays higher dividends than JIBCX: VIGRX (0.32) vs JIBCX (0.00). JIBCX was incepted earlier than VIGRX: JIBCX (20 years) vs VIGRX (33 years). JIBCX (0.82) is less costly to investors than VIGRX (0.17). JIBCX is a more actively managed with annual turnover of: 12.00 vs. VIGRX (11.00). JIBCX has a lower initial minimum investment than VIGRX: JIBCX (0) vs VIGRX (3000). VIGRX annual gain was more profitable for investors over the last year : 24.03 vs. JIBCX (15.48). VIGRX return over 5 years is better than : 107.21 vs. JIBCX (29.48).
JIBCXVIGRXJIBCX / VIGRX
Total Expense Ratio0.810.17476%
Annual Report Gross Expense Ratio0.820.17482%
Fund Existence20 years33 years-
Gain YTD13.07912.580104%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets5.91B324B2%
Annual Yield % from dividends0.000.32-
Returns for 1 year15.4824.0364%
Returns for 3 years55.1173.6875%
Returns for 5 years29.48107.2127%
Returns for 10 years84.55321.5126%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NKTR27.260.57
+2.14%
Nektar Therapeutics
SUPN42.690.52
+1.23%
Supernus Pharmaceuticals
FTAI144.72-0.18
-0.12%
FTAI Aviation Ltd
SBFM1.49-0.02
-1.33%
Sunshine Biopharma Inc
AXTI2.05-0.11
-5.09%
AXT